Literature DB >> 20399032

Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer.

Hitoshi Ikushima1, Peter Balter, Ritsuko Komaki, Sandeep Hunjun, M Kara Bucci, Zhongxing Liao, Mary F McAleer, Zhiqian H Yu, Yongbin Zhang, Joe Y Chang, Lei Dong.   

Abstract

PURPOSE: To determine the extent of interfractional setup errors and day-to-day organ motion errors by assessing daily bone alignment results and changes in soft tissue tumor position during hypofractionated, in-room computed tomography (CT)-guided stereotactic body radiation therapy (SBRT) of lung cancer. METHODS AND MATERIALS: Daily alignment results during SBRT were analyzed for 117 tumors in 112 patients. Patients received 40-50 Gy of SBRT in four to five fractions using an integrated CT-LINAC system. The free-breathing CT scans acquired during treatment setup were retrospectively realigned to match with each of the bony references and the gross tumor volume (GTV) defined on the reference CT by rigid-body registration, and the daily deviations were calculated.
RESULTS: The mean magnitude (± SD) three-dimensional shift from the initial skin marks to the final bone-aligned positions was 9.4 ± 5.7 mm. The mean daily GTV deviation from the bone position was 0.1 ± 3.8 mm in the anterior-posterior direction, -0.01 ± 4.2 mm in the superior-inferior direction, and 0.2 ± 2.5 mm in the lateral direction. A clinically noteworthy trend (net change >5 mm in any direction) in GTV position relative to the bone was observed in 23 cases (20%).
CONCLUSIONS: Soft tissue target position can change significantly beyond the motion envelope defined in the original internal target volume in four-dimensional CT-based treatment planning for SBRT of lung cancer. Additional margin should be considered for adequate coverage of interfractional changes. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20399032     DOI: 10.1016/j.ijrobp.2009.11.009

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Stereotactic ablative body radiotherapy for non-small-cell lung cancer: setup reproducibility with novel arms-down immobilization.

Authors:  Karen Moore; Claire Paterson; Jonathan Hicks; Stephen Harrow; Mark McJury
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

2.  Ionizing radiation selectively reduces skin regulatory T cells and alters immune function.

Authors:  Yu Zhou; Houping Ni; Klara Balint; Jenine K Sanzari; Tzvete Dentchev; Eric S Diffenderfer; Jolaine M Wilson; Keith A Cengel; Drew Weissman
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

3.  Interfractional variations of tumor centroid position and tumor regression during stereotactic body radiotherapy for lung tumor.

Authors:  Yanan Sun; Yufei Lu; Siguo Cheng; Wei Guo; Ke Ye; Huiyun Zhao; Xiaoli Zheng; Dingjie Li; Shujuan Wang; Chengliang Yang; Hong Ge
Journal:  Biomed Res Int       Date:  2014-12-07       Impact factor: 3.411

4.  The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer.

Authors:  Wambaka Ange Mampuya; Yukinori Matsuo; Nami Ueki; Mitsuhiro Nakamura; Nobutaka Mukumoto; Akira Nakamura; Yusuke Iizuka; Takahiro Kishi; Takashi Mizowaki; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2014-05-06       Impact factor: 2.724

5.  Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.

Authors:  Yanan Sun; Hong Ge; Siguo Cheng; Chengliang Yang; Qianqian Zhu; Dingjie Li; Yuan Tian
Journal:  J Appl Clin Med Phys       Date:  2016-03-08       Impact factor: 2.102

Review 6.  The impact of technology on the changing practice of lung SBRT.

Authors:  Marianne Camille Aznar; Samantha Warren; Mischa Hoogeman; Mirjana Josipovic
Journal:  Phys Med       Date:  2018-01-10       Impact factor: 2.685

7.  Hypofractionated 192Ir source stereotactic ablative brachytherapy with coplanar template assistance in the primary treatment of peripheral lung cancer.

Authors:  Haowen Pang; Kui Wu; Xiangxiang Shi; Tao Tang; Xiaoyang Sun; Bo Yang; Jingbo Wu; Sheng Lin
Journal:  J Contemp Brachytherapy       Date:  2019-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.